- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glomerulonephritis, IGA in Australia
Total 69 results
-
The George InstitutePeking University First HospitalCompletedIgA GlomerulonephritisCanada, China, Australia, Malaysia, Hong Kong, India
-
Rigel PharmaceuticalsCompletedIGA NephropathyUnited States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
-
Eledon PharmaceuticalsTerminatedIgA Nephropathy | IgANAustralia, Spain, Thailand, New Zealand, Croatia, Malaysia, Philippines, Poland, Sri Lanka, United Kingdom
-
Ionis Pharmaceuticals, Inc.Active, not recruitingPrimary IgA NephropathyCanada, Australia, New Zealand, Singapore
-
The George InstitutePeking University Institute of NephrologyRecruitingKidney Diseases | Glomerulonephritis | ESRD | IgA NephropathyAustralia, China, Canada, Hong Kong, India, Malaysia
-
Novartis PharmaceuticalsCompletedIgA NephropathyColombia, Taiwan, Czechia, India, Turkey, Belgium, Netherlands, Singapore, Australia, Korea, Republic of, Thailand, Argentina, Germany, Israel, Japan, Sweden, United Kingdom, Brazil, China, Hong Kong, Norway, Finland, France, Denmark, M...
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
Chinook Therapeutics, Inc.RecruitingImmunoglobulin A Nephropathy | IgA NephropathySpain, Australia, United States
-
Hoffmann-La RocheRecruitingPrimary IgA NephropathyKorea, Republic of, Australia, Spain, United Kingdom, China, France, Taiwan, United States, Italy, Greece, Czechia, Singapore, Japan, Argentina, Germany, Brazil, Poland
-
HI-BioActive, not recruitingImmunoglobulin A (IgA) NephropathyUnited Kingdom, Germany, Spain, Serbia, Taiwan, Australia, Japan, Korea, Republic of, Belgium, United States, Bulgaria, Czechia, Georgia, Malaysia, Philippines, Ukraine
-
Arrowhead PharmaceuticalsRecruitingIgA Nephropathy | C3 GlomerulopathyNew Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
-
Visterra, Inc.CompletedImmunoglobulin A Nephropathy | Glomerular Disease | IgANUnited States, Australia, Canada, Hong Kong, India, Japan, Korea, Republic of, Malaysia, Philippines, Singapore, Spain, Sri Lanka, Taiwan, Thailand, United Kingdom
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyUnited States, Australia, Taiwan, Spain, Canada, Argentina, Belarus, Belgium, Czechia, Finland, France, Germany, Greece, Italy, Korea, Republic of, Poland, Sweden, Turkey, United Kingdom
-
Omeros CorporationTerminatedIgA NephropathyUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, United Kingdom
-
Alexion Pharmaceuticals, Inc.RecruitingImmunoglobulin A Nephropathy | IgANSpain, United Kingdom, United States, Italy, Belgium, Germany, Colombia, Japan, China, France, Korea, Republic of, Thailand, Australia, Canada, Brazil, Malaysia, Poland, Taiwan, Austria, Greece, Israel, Netherlands, Argentina, Mexico, S... and more
-
Chinook Therapeutics, Inc.RecruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Canada, Australia, Argentina, Korea, Republic of
-
Chinook Therapeutics U.S., Inc.Active, not recruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Spain, Canada, Taiwan, Hong Kong, China, New Zealand, United Kingdom, Korea, Republic of, Australia, Germany, France, India, Japan, Czechia, Argentina, Italy, Colombia, Ireland, Brazil, Poland, Portugal
-
Novartis PharmaceuticalsActive, not recruitingIgA NephropathyUnited States, Taiwan, Czechia, Germany, Hungary, India, Turkey, Belgium, Netherlands, Singapore, Australia, Canada, Italy, Korea, Republic of, Spain, Thailand, Denmark, Slovenia, United Kingdom, Argentina, Brazil, Israel, Japan, France, Swed... and more
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
Alexion Pharmaceuticals, Inc.RecruitingLupus Nephritis | Immunoglobulin A Nephropathy | IgAN | LNAustralia, Spain, United Kingdom, China, Germany, Italy, Argentina, Peru, Korea, Republic of, Taiwan, Thailand, United States, Serbia, Israel, Brazil, Turkey, Mexico, Russian Federation
-
Travere Therapeutics, Inc.Active, not recruitingImmunoglobulin A NephropathyUnited States, Australia, Belgium, Croatia, Czechia, Estonia, France, Germany, Hong Kong, Italy, Korea, Republic of, Lithuania, New Zealand, Poland, Portugal, Spain, Taiwan, United Kingdom
-
AlexionRecruitingLupus Nephritis | Immunoglobulin A NephropathyUnited States, Australia, Canada, France, Germany, Italy, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
The University of QueenslandUniversity of AdelaideNot yet recruitingPrimary Membranous NephropathyAustralia
-
Alpine Immune Sciences, Inc.RecruitingLupus Nephritis | Immunoglobulin A Nephropathy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Membranous NephropathyUnited States, Australia, Korea, Republic of
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Melbourne HealthCompletedDiabetic Nephropathy | Proteinuria | Glomerulonephritis | Kidney DiseaseAustralia
-
Dimerix Bioscience Pty LtdIqvia Pty LtdCompletedFocal Segmental GlomerulosclerosisAustralia
-
GlaxoSmithKlineWithdrawnGlomerulonephritis, MembranousAustralia, Spain, United States, Canada, Germany, Netherlands, France, United Kingdom, Czech Republic, Italy
-
HI-BioCompletedTrial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (M-PLACE)Glomerulonephritis, Membranous | antiPLA2R PositiveSpain, Belgium, Australia, Italy, United States, Korea, Republic of, France, Netherlands, Poland
-
Baxalta now part of ShireTerminatedSystemic Lupus ErythematosusAustralia, United States, New Zealand, Mexico, Canada
-
Christoph AufrichtRecruitingProteinuria | Focal Segmental Glomerulosclerosis | Nephrotic Syndrome | Nephrotic Syndrome Steroid-ResistantAustria
-
Medical University of ViennaMedical University of Graz; Radboud University Medical Center; Charite University... and other collaboratorsTerminatedLupus Erythematosus, Systemic | Lupus NephritisAustria, Germany, Netherlands
-
La Jolla Pharmaceutical CompanyCompletedAutoimmune Diseases | Systemic Lupus Erythematosus | Lupus Nephritis | Immunologic Diseases | Lupus GlomerulonephritisUnited States, Austria, Canada, France, Germany, Italy, Mexico, Spain, Sweden, United Kingdom
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis IVA (Morquio A Syndrome)Australia
-
Novartis PharmaceuticalsRecruitingSystemic Lupus Erythematosus | Lupus NephritisSpain, Switzerland, Germany, Australia, France
-
TakedaActive, not recruitingGlomerulonephritis | Kidney DiseaseTaiwan, Australia, Hungary, Spain, United Kingdom, United States, China, Korea, Republic of, Italy, Japan, Singapore
-
Boehringer IngelheimCompletedLupus NephritisUnited Kingdom, Thailand, Germany, Japan, United States, Australia, Korea, Republic of, Hong Kong, Poland, Greece, Mexico, Czechia, Canada, Malaysia, Philippines, Portugal
-
Mårten SegelmarkHansa Biopharma ABCompletedAnti-Glomerular Basement Membrane Antibody DiseaseAustria, Czechia, Denmark, France, Sweden
-
Bristol-Myers SquibbTerminatedLupus NephritisUnited States, Taiwan, Spain, United Kingdom, Netherlands, Germany, China, Australia, Belgium, Mexico, Korea, Republic of, Czechia, Russian Federation, Israel, Canada, Italy
-
Bristol-Myers SquibbTerminatedLupus NephritisAustralia, China, Italy, Taiwan, Turkey, United States, Hong Kong, Spain, Russian Federation, Korea, Republic of, Japan, Israel, Romania, Puerto Rico, Argentina, Brazil, Canada, Chile, Colombia, Czechia, India, Mexico, Peru
-
IpsenRecruitingIGF1 DeficiencySpain, United States, Italy, France, United Kingdom, Germany, Austria, French Guiana, Poland, Sweden, Martinique
-
BiogenTerminatedLupus NephritisBelgium, Peru, Italy, Malaysia, Australia, Argentina, United States, Hong Kong, Hungary, Poland, Colombia, Russian Federation, Philippines, Brazil, France, Korea, Republic of, Mexico, Spain, Thailand
-
ChemoCentryxMedpace, Inc.CompletedFocal Segmental Glomerulosclerosis | FSGS | GlomerulosclerosisUnited States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
-
Mallinckrodt ARD LLCCompletedIdiopathic Focal Segmental GlomerulosclerosisUnited States, Argentina, Turkey, Peru, Australia, Chile, Mexico
-
AstraZenecaParexelCompletedLupus NephritisUnited States, Italy, Spain, Taiwan, Peru, Belgium, France, Korea, Republic of, Mexico, Germany, Australia, Hungary, Serbia, Russian Federation, United Kingdom, Poland, Argentina
-
Novartis PharmaceuticalsTerminatedLupus NephritisCzechia, Australia, Spain, Thailand, Brazil, Portugal, Vietnam, Korea, Republic of, Colombia, Guatemala, Slovakia, Philippines, Japan